Published in Br J Pharmacol on December 01, 2009
Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. BMJ (2012) 0.90
Synthetic gestagens exert differential effects on arterial thrombosis and aortic gene expression in ovariectomized apolipoprotein E-deficient mice. Br J Pharmacol (2014) 0.75
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA (2004) 23.69
Guide to Receptors and Channels (GRAC), 3rd edition. Br J Pharmacol (2008) 13.18
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA (2007) 10.50
Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med (2003) 10.06
Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA (2003) 5.26
A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med (2000) 5.17
Estrogen plus progestin and risk of venous thrombosis. JAMA (2004) 3.46
A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med (1985) 3.21
Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (1999) 2.59
Hyaluronan-cell interactions in cancer and vascular disease. J Biol Chem (2001) 2.45
Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2001) 1.79
Murine models of vascular thrombosis (Eitzman series). Arterioscler Thromb Vasc Biol (2007) 1.74
Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arteriosclerosis (1990) 1.73
Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm. Nat Med (1997) 1.70
Effect of medroxyprogesterone acetate on vascular inflammatory markers in postmenopausal women receiving estrogen. Circulation (2002) 1.52
Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Cardiovasc Res (2005) 1.51
Platelet-derived growth factor-BB represses smooth muscle cell marker genes via changes in binding of MKL factors and histone deacetylases to their promoters. Am J Physiol Cell Physiol (2006) 1.44
Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery. Circulation (2003) 1.43
Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A (1996) 1.35
Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arterioscler Thromb Vasc Biol (1997) 1.32
Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion. Arterioscler Thromb Vasc Biol (2002) 1.31
Plaque-associated endothelial dysfunction in apolipoprotein E-deficient mice on a regular diet. Effect of human apolipoprotein AI. Cardiovasc Res (2003) 1.29
Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial. Arterioscler Thromb Vasc Biol (1997) 1.21
Chronic ultraviolet B irradiation causes loss of hyaluronic acid from mouse dermis because of down-regulation of hyaluronic acid synthases. Am J Pathol (2007) 1.15
17 beta-estradiol prevents fatty streak formation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (1997) 1.10
Endogenous vascular hydrogen peroxide regulates arteriolar tension in vivo. Circulation (2005) 1.08
Effect of mechanical ventilation on carotid artery thrombosis induced by photochemical injury in mice. J Thromb Haemost (2003) 1.02
Protection against atherosclerosis by estrogen is independent of plasma cholesterol levels in LDL receptor-deficient mice. J Lipid Res (1999) 1.02
Dexamethasone-induced suppression of aortic atherosclerosis in cholesterol-fed rabbits. Possible mechanisms. Arterioscler Thromb (1993) 0.99
Sex steroids used in hormonal treatment increase vascular procoagulant activity by inducing thrombin receptor (PAR-1) expression: role of the glucocorticoid receptor. Circulation (2001) 0.99
Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells. Endocrinology (2004) 0.96
Progesterone antagonizes the vasoprotective effect of estrogen on antioxidant enzyme expression and function. Circ Res (2005) 0.93
Inhibition of the protective effect of estrogen by progesterone in experimental atherosclerosis. Atherosclerosis (1996) 0.89
Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells. Breast Cancer Res Treat (1989) 0.87
Endothelial function in aorta segments of apolipoprotein E-deficient mice before development of atherosclerotic lesions. Pflugers Arch (2007) 0.87
Medroxyprogesterone acetate downregulates cytokine gene expression in mouse fibroblast cells. Mol Cell Endocrinol (2004) 0.86
Regulation of platelet aggregation and adenosine triphosphate release in vitro by 17beta-estradiol and medroxyprogesterone acetate in postmenopausal women. Thromb Haemost (2000) 0.82
Noncontraceptive benefits and therapeutic uses of depot medroxyprogesterone acetate. J Reprod Med (1996) 0.81
Progestins overcome inhibition of platelet aggregation by endothelial cells by down-regulating endothelial NO synthase via glucocorticoid receptors. FASEB J (2006) 0.80
The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease: results from the estrogen in women with atherosclerosis study. Thromb Res (2000) 0.79
Multiple actions of synthetic 'progestins' on the growth of ZR-75-1 human breast cancer cells: an in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids. Breast Cancer Res Treat (1991) 0.79
Effects of hormone replacement therapy on blood coagulation and fibrinolysis in hypertensive and normotensive postmenopausal women. Thromb Res (2005) 0.78
Norgestimate and medroxyprogesterone acetate do not attenuate the atheroprotective effects of 17beta-estradiol in ovariectomized, apolipoprotein E-deficient mice. Fertil Steril (2004) 0.76
Green tea catechins containing a galloyl group in the 3' position inhibit tissue factor-induced thrombin generation. Thromb Haemost (2005) 0.76
A randomized trial of icatibant in ACE-inhibitor-induced angioedema. N Engl J Med (2015) 4.75
Biosimilars: what clinicians should know. Blood (2012) 2.28
Human vascular smooth muscle cells express functionally active endothelial cell protein C receptor. Circ Res (2006) 2.17
Derivatives of 1,5-diamino-1H-tetrazole: a new family of energetic heterocyclic-based salts. Inorg Chem (2005) 2.07
Aspirin in the chemoprevention of colorectal neoplasia: an overview. Cancer Prev Res (Phila) (2011) 2.03
Transoral open reduction and fixation of mandibular condylar base and neck fractures in children and young teenagers--a beneficial treatment option? J Oral Maxillofac Surg (2013) 2.03
Alternatively spliced human tissue factor (asHTF) is not pro-coagulant. Thromb Haemost (2007) 1.75
Biosimilars-why terminology matters. Nat Biotechnol (2011) 1.73
Epidermal EGFR controls cutaneous host defense and prevents inflammation. Sci Transl Med (2013) 1.69
(E)-3-Hydr-oxy-N'-(2-hydroxy-benzyl-idene)-2-naphthohydrazide. Acta Crystallogr Sect E Struct Rep Online (2009) 1.55
Impact of clopidogrel loading dose on clinical outcome in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Heart (2010) 1.53
Inhibition of vascular oxidative stress in hypercholesterolemia by eccentric isosorbide mononitrate. J Am Coll Cardiol (2004) 1.48
Preserved endothelial function after long-term eccentric isosorbide mononitrate despite moderate nitrate tolerance. J Am Coll Cardiol (2003) 1.44
Vasoprotection by nitric oxide: mechanisms and therapeutic potential. Cardiovasc Res (2002) 1.42
Differential bilingual laterality: mythical monster found in Wales. Brain Lang (2002) 1.42
BTA copper complexes. Inorg Chem (2005) 1.41
A novel function of FoxO transcription factors in thrombin-stimulated vascular smooth muscle cell proliferation. Thromb Haemost (2012) 1.41
Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series. Ann Emerg Med (2010) 1.35
Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol (2008) 1.30
Hemodynamic and biochemical adaptations to vascular smooth muscle overexpression of p22phox in mice. Am J Physiol Heart Circ Physiol (2004) 1.26
Protein kinase G controls brown fat cell differentiation and mitochondrial biogenesis. Sci Signal (2009) 1.24
Total synthesis of the cytostatic marine natural product dibromophakellstatin via three-component imidazolidinone anellation. J Org Chem (2006) 1.23
Survivin determines cardiac function by controlling total cardiomyocyte number. Circulation (2008) 1.18
Chronic ultraviolet B irradiation causes loss of hyaluronic acid from mouse dermis because of down-regulation of hyaluronic acid synthases. Am J Pathol (2007) 1.15
Hyaluronan stabilizes focal adhesions, filopodia, and the proliferative phenotype in esophageal squamous carcinoma cells. J Biol Chem (2010) 1.15
Prevention of dipyrone (metamizole) induced inhibition of aspirin antiplatelet effects. Thromb Haemost (2015) 1.14
Deficiency of biglycan causes cardiac fibroblasts to differentiate into a myofibroblast phenotype. J Biol Chem (2011) 1.10
Increased cGMP promotes healthy expansion and browning of white adipose tissue. FASEB J (2013) 1.09
1,5-diamino-4-methyltetrazolium dinitramide. J Am Chem Soc (2005) 1.09
Endogenous vascular hydrogen peroxide regulates arteriolar tension in vivo. Circulation (2005) 1.08
Inhibition of oesophageal squamous cell carcinoma progression by in vivo targeting of hyaluronan synthesis. Mol Cancer (2011) 1.06
Syndecan-4 is required for thrombin-induced migration and proliferation in human vascular smooth muscle cells. J Biol Chem (2005) 1.04
Critical involvement of hydrogen peroxide in exercise-induced up-regulation of endothelial NO synthase. Cardiovasc Res (2005) 1.04
Highly diastereoselective Csp₃-Csp₂ Negishi cross-coupling with 1,2-, 1,3- and 1,4-substituted cycloalkylzinc compounds. Nat Chem (2010) 1.03
Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells. J Biol Chem (2002) 1.02
Inhibition of hyaluronan synthesis accelerates murine atherosclerosis: novel insights into the role of hyaluronan synthesis. Circulation (2010) 1.02
Microarray analysis of genes expressed in the frontal cortex of rats chronically treated with morphine and after naloxone precipitated withdrawal. Brain Res Mol Brain Res (2003) 1.02
Towards a definition of aspirin resistance: a typological approach. Platelets (2002) 1.00
Highly diastereoselective arylations of substituted piperidines. J Am Chem Soc (2011) 1.00
Dipyrone (metamizole) can nullify the antiplatelet effect of aspirin in patients with coronary artery disease. J Am Coll Cardiol (2013) 1.00
Microglia activation in hepatic encephalopathy in rats and humans. Hepatology (2011) 0.99
Ultrafast intramolecular charge transfer with N-(4-cyanophenyl)carbazole. Evidence for a LE precursor and dual LE + ICT fluorescence. J Phys Chem A (2010) 0.99
Collagen fragments inhibit hyaluronan synthesis in skin fibroblasts in response to ultraviolet B (UVB): new insights into mechanisms of matrix remodeling. J Biol Chem (2011) 0.99
A Social Assistive Robot in an Intelligent Environment. Biomed Tech (Berl) (2013) 0.98
Hirudin--the long and stony way from an anticoagulant peptide in the saliva of medicinal leech to a recombinant drug and beyond. A historical piece. Thromb Haemost (2007) 0.97
(Cyclo-pentane-1,1-di-yl)dimethanol. Acta Crystallogr Sect E Struct Rep Online (2009) 0.97
Regulation of hyaluronan synthesis by vasodilatory prostaglandins. Implications for atherosclerosis. Thromb Haemost (2007) 0.97
Evidence for functionally active protease-activated receptor-3 (PAR-3) in human vascular smooth muscle cells. Thromb Haemost (2003) 0.96
Toward the total synthesis of maoecrystal V: establishment of contiguous quaternary stereocenters. Org Lett (2010) 0.95
Smooth muscle cell biglycan overexpression results in increased lipoprotein retention on extracellular matrix: implications for the retention of lipoproteins in atherosclerosis. Atherosclerosis (2004) 0.95
Toll-like receptor 4 is involved in human and mouse vein graft remodeling, and local gene silencing reduces vein graft disease in hypercholesterolemic APOE*3Leiden mice. Arterioscler Thromb Vasc Biol (2011) 0.95
A Laboratory for AAL Applications. Biomed Tech (Berl) (2013) 0.94
Increased plasmin and serine proteinase activity during flow-induced intimal atrophy in baboon PTFE grafts. Arterioscler Thromb Vasc Biol (2002) 0.94
Response variability to P2Y12 receptor inhibitors: expectations and reality. JACC Cardiovasc Interv (2013) 0.94
Estradiol protects dermal hyaluronan/versican matrix during photoaging by release of epidermal growth factor from keratinocytes. J Biol Chem (2012) 0.93
Assessment of proximal finger joint inflammation in patients with rheumatoid arthritis, using a novel laser-based imaging technique. Arthritis Rheum (2002) 0.93
2,2'-Diamino-N,N'-(o-phenyl-ene)di-benz-amide. Acta Crystallogr Sect E Struct Rep Online (2009) 0.93
Isolation of a copper(I) triazolide: a "click" intermediate. Angew Chem Int Ed Engl (2007) 0.93
Synthesis, cytotoxic effect, and structure-activity relationship of Pd(II) complexes with coumarin derivatives. Inorg Chem (2006) 0.93
Critical role of endothelial hydrogen peroxide in post-ischemic neovascularization. PLoS One (2013) 0.92
Alzheimer's disease, cerebrovascular dysfunction and the benefits of exercise: from vessels to neurons. Exp Gerontol (2008) 0.92
Pharmacophore definition and three-dimensional quantitative structure-activity relationship study on structurally diverse prostacyclin receptor agonists. Mol Pharmacol (2002) 0.92
Benzhydryl phenyl sulfone. Acta Crystallogr Sect E Struct Rep Online (2009) 0.92
4,4'-Bis(dimethyl-amino)benzhydryl phenyl sulfone. Acta Crystallogr Sect E Struct Rep Online (2009) 0.91
Thienopyridines in cardiovascular disease: focus on clopidogrel resistance. Thromb Haemost (2007) 0.91
Simple, nitrogen-rich, energetic salts of 5-nitrotetrazole. Inorg Chem (2008) 0.91
Physical inactivity causes endothelial dysfunction in healthy young mice. J Am Coll Cardiol (2004) 0.90
A novel low molecular weight inhibitor of dendritic cells and B cells blocks allergic inflammation. Am J Respir Crit Care Med (2005) 0.90
m-Phenyl-enediamine. Acta Crystallogr Sect E Struct Rep Online (2008) 0.90
Accumulation and loss of extracellular matrix during shear stress-mediated intimal growth and regression in baboon vascular grafts. J Histochem Cytochem (2005) 0.90
Selective cyclooxygenase-2 inhibition upregulates renal cortical alpha V integrin expression. Nephron Exp Nephrol (2003) 0.89
Mechanisms of the inhibitory effects of epigallocatechin-3 gallate on platelet-derived growth factor-BB-induced cell signaling and mitogenesis. FASEB J (2003) 0.89
Regulation of thrombomodulin expression in human vascular smooth muscle cells by COX-2-derived prostaglandins. Circ Res (2004) 0.88
Analysis of risk factors for urinary incontinence after radical prostatectomy. Urol Int (2007) 0.88
Binary tellurium(IV) azides: Te(N3)4 and [Te(N3)5]-. Angew Chem Int Ed Engl (2003) 0.88
Nucleophilicity parameters of pyridinium ylides and their use in mechanistic analyses. J Am Chem Soc (2013) 0.87
Complex effects of different green tea catechins on human platelets. FEBS Lett (2003) 0.87
Integrin-mediated transcriptional activation of inhibitor of apoptosis proteins protects smooth muscle cells against apoptosis induced by degraded collagen. Circ Res (2006) 0.87
Overexpression of prostaglandin EP3 receptors activates calcineurin and promotes hypertrophy in the murine heart. Cardiovasc Res (2008) 0.87
Morphine induces late cardioprotection in rat hearts in vivo: the involvement of opioid receptors and nuclear transcription factor kappaB. Anesth Analg (2005) 0.87
Thrombin receptors in vascular smooth muscle cells - function and regulation by vasodilatory prostaglandins. Thromb Haemost (2010) 0.87
High insulin-like growth factor mRNA-binding protein 3 (IMP3) protein expression is associated with poor survival in muscle-invasive bladder cancer. BJU Int (2012) 0.87
ICAM-1 and p38 MAPK mediate fibrinogen-induced migration of human vascular smooth muscle cells. Eur J Pharmacol (2007) 0.87
Aberrant mural cell recruitment to lymphatic vessels and impaired lymphatic drainage in a murine model of pulmonary fibrosis. Blood (2012) 0.87
Proatherogenic effects of estradiol in a model of accelerated atherosclerosis in ovariectomized ApoE-deficient mice. Basic Res Cardiol (2010) 0.86
Oral administration of specific antigens to allergy-prone infant dogs induces IL-10 and TGF-beta expression and prevents allergy in adult life. J Allergy Clin Immunol (2003) 0.86